Hope S. Rugo, MD
Advertisement

Hope S. Rugo, MD, is the Director of the Women's Cancers Program, the Division Chief of Breast Medical Oncology, and a Professor in the Department of Medical Oncology & Therapeutics Research at City of Hope Comprehensive Cancer Center. She is also a Professor Emeritus at UCSF
Articles by Hope S. Rugo, MD
Advertisement
Latest Updated Articles
Novel Therapy for Relapsed/Refractory HR+ BC: Oral SERDsPublished: August 1st 2022 | Updated:
Real-World Use of CDK4/6 Inhibition in HR+/HER2- Breast CancerPublished: July 11th 2022 | Updated:
Frontline Combination Strategies in HR+/HER2- BCPublished: July 18th 2022 | Updated:
Dr. Rugo on Recent Updates With Immunotherapy in TNBCPublished: May 19th 2020 | Updated:
Dr Rugo on Research Needed to Clarify the Role of T-DXd Plus Pertuzumab in HER2+ Breast CancerPublished: June 6th 2025 | Updated:
Novel Treatment Approaches to Relapsed/Refractory HR+ Breast CancerPublished: July 25th 2022 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5

